|
PF-40750 |
TARIA 500 mg capsulas |
2013-06-19 |
|
North China Pharmaceutical Group Corp. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-40749 |
DAVOS 1.2 g liofilizado para uso parenteral |
2013-06-19 |
|
North China Pharmaceutical Group Corp. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-40887 |
BANKER 1 g liofilizado para uso parenteral |
2013-07-10 |
|
North China Pharmaceutical Group Corp. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41621 |
MEROPENEM North China 0.5 g Liofilizado para uso parenteral |
2013-10-16 |
|
North China Pharmaceutical Group Corp. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38214 |
AMOXICILINA+CLAVULANATO POTASICO North China 500mg/125 mg * |
2011-11-16 |
|
North China Pharmaceutical Group Formulation Co., Ltd. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38218 |
CEFTRIAXONA SODICA Diagnopharm 1.0 g Liofilizado para Uso Parenteral |
2011-11-17 |
|
Diagnopharm, S.A. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38387 |
AMPICILINA SODICA North China 1.0 g Liofilizado para Uso Parenteral |
2012-01-30 |
|
North China Pharmaceutical Group Formulation Co., Ltd. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38621 |
AMOXICILINA North China 500 mg Capsulas |
2012-03-28 |
|
North China Pharmaceutical Group Formulation Co., Ltd. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43930 |
RANITIDINA CLORHIDRATO North China Solución inyectable |
2014-12-02 |
|
North China Pharmaceutical Group Formulation Co., Ltd. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44267 |
METFORMINA CLORHIDRATO NCPGF 850 mg tabletas |
2015-03-04 |
|
North China Pharmaceutical Group Formulation Co., Ltd. |
República de China
|
Diagnopharm, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|